GADD45A and neoplasm: Moreover, in terms of the 5-year survival rate, we found that RCC patients with higher GADD45A tumor expression had significantly better outcomes than those with lower expression, further implicating the potential of GADD45A as a predictor of outcomes in RCC patients.